Key result
Higher admission hemoglobin is linked to ~13% lower cardiogenic shock mortality per 1 g/dL.
Why the study?
Anemia is common in cardiogenic shock, but its prognostic role across cardiogenic shock etiologies and the relevance of early Hb changes remained uncertain.
Are admission and 24-hour hemoglobin levels independently associated with in-hospital mortality in patients with cardiogenic shock?
Cohort (n=817)
Yes
Are admission and 24-hour hemoglobin levels independently associated with in-hospital mortality in patients with cardiogenic shock?
In patients with cardiogenic shock, lower admission hemoglobin is independently associated with higher in-hospital mortality across etiologies, whereas 24-hour hemoglobin changes offer no additional prognostic value.
Answers are grounded in this paper and cite their sources.
Admission hemoglobin may aid risk stratification in cardiogenic shock; hypothesis-generating and requires prospective validation before guiding care.
Background Anemia is common in cardiogenic shock and may further impair oxygen delivery in a setting of reduced cardiac output. However, its prognostic role across cardiogenic shock etiologies and the relevance of early hemoglobin (Hb) changes remain uncertain. Methods This analysis included 817 patients enrolled between March 2020 and November 2024 in the prospective multicenter Altshock-2 registry. Anemia was defined using WHO sex-specific criteria, and admission Hb was categorized into tertiles. The primary endpoint was in-hospital mortality. Associations of admission and 24-h Hb with mortality were evaluated using logistic regression adjusted for demographics, comorbidities, and cardiogenic shock etiology (model A) or metabolic and hemodynamic severity (model B). Results Anemia was present in 415 patients (50.8%) at admission and in 533 (67%) at 24 h. In-hospital mortality decreased across increasing admission Hb tertiles (44.2, 29.3, and 21.5% in T1, T2, and T3, respectively; P < 0.001). Admission Hb was inversely associated with primary endpoint in both model A [adjusted odds ratio (aOR) per 1 g/dl increase 0.87; 95% confidence interval (CI) 0.80–0.93; P < 0.001] and model B (aOR 0.87; 95% CI 0.81–0.93; P < 0.001). After accounting for admission Hb, 24-h Hb was not independently associated with the primary endpoint and did not improve model fit (likelihood-ratio P = 0.264 and P = 0.577 for models A and B) nor discrimination (ΔAUC = 0.001 and −0.001, respectively). There was no statistical evidence of effect modification by cardiogenic shock etiology or sex. Conclusion Lower admission Hb was independently associated with increased in-hospital mortality. In contrast, 24-h Hb provided no incremental prognostic information beyond admission Hb. Admission Hb may therefore contribute to multidimensional risk assessment in patients with cardiogenic shock.
No takes yet. Share an insight, caveat, or question.
Bertaina et al. (2026) conducted a cohort in Cardiogenic shock (n=817). Admission and 24-hour hemoglobin levels vs. Across admission hemoglobin tertiles (T1, T2, T3) and per 1 g/dL increase was evaluated on In-hospital mortality (aOR 0.87 per 1 g/dl increase, 95% CI 0.80-0.93, p=<0.001). Higher admission hemoglobin was inversely associated with in-hospital mortality in cardiogenic shock, whereas 24-h Hb added no prognostic value.
Synapse has enriched 10 related papers. Consider them for comparative context: